The Exchange has received the disclosure under Regulation 29(1) / 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Milly Chetan Lalseta
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Promoter Milly Chetan Lalseta acquired 18,000 equity shares of Aptus Pharma Limited on May 11, 2026 through an inter-se transfer within the promoter group. Before the acquisition, she held 5,75,000 shares (8.38% of total capital). After the acquisition, her holding increased to 5,93,000 shares representing 8.64% of the company's total voting capital of 68,60,000 equity shares. The company is listed on BSE's SME platform with scrip code 544529. This is a routine promoter-to-promoter share transfer that increases the acquiring promoter's stake in the company.
This is a routine intra-promoter group transaction and has neutral impact on the stock. It does not change the total promoter group holding and is unlikely to affect share price or minority shareholder interests.